TE

Travis Engelman

VP M&a Business Development & Strategy, Biotechnology Group (cytiva/pall) at Danaher

About

Links

Previous companies

Align Technology logo
Novartis logo
Thermo Fisher Scientific logo
Merck logo

Peers

View in org chart

Timeline

  • VP M&a Business Development & Strategy, Biotechnology Group (cytiva/pall)

    December, 2021 - present

  • Vice President, M&a Business Development & Strategy, EAS Platform

    February, 2021

  • Vice President Business Development

    April, 2016

A panel showing how The Org can help with contacting the right person.